Featured Research

from universities, journals, and other organizations

Older age marker may be more appropriate for papillary thyroid cancer prognosis

Date:
September 21, 2012
Source:
American Thyroid Association
Summary:
Although age 45 is used to establish staging in well-differentiated papillary thyroid cancer using the American Joint Committee on Cancer and the International Union Against Cancer TNM Classification of Malignant Tumors (TNM) staging system, a new study suggests that > 65 may be a more accurate age marker for prognosis.

Although age 45 is used to establish staging in well-differentiated papillary thyroid cancer using the American Joint Committee on Cancer and the International Union Against Cancer TNM Classification of Malignant Tumors (TNM) staging system, a new study presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada, suggests that > 65 may be a more accurate age marker for prognosis.

"While age at diagnosis appears to play a role in papillary thyroid cancer outcomes, new data suggest that a more appropriate age marker for prognosis is > 65 years," said Elizabeth Pearce, MD, of the Boston Medical Center and Program Co-Chair of the ATA annual meeting. "Use of this older age marker would result in down-staging of many patients, reflecting a more favorable prognosis that could avoid potentially unnecessary therapies and allay patients' fears about their longevity."

A review of the literature to determine the origin of this age marker appears to date back to an article by Byar, et al., published in European Journal of Cancer in 1979, that was underpowered and not specific to well-differentiated thyroid cancer. In addition, empiric clinical observations often suggest that patients aged 45 to 64 years appear to have similar long-term outcomes when compared to patients < 45 years of age.

A team of researchers led by Lindsay Bischoff, MD, of the Thomas Jefferson University Hospital in Philadelphia, Pa., thus conducted a study to determine the accuracy of age 45 as a prognostic cut-off. They performed a search of the Surveillance, Epidemiology, and End Result (SEER) database to obtain data for histology-confirmed papillary thyroid cancer. Data were stratified in 5-year categories by age at diagnosis from 20 to 84 years old, with patients 85 years of age and older categorized together. All stages, race/ethnicity groups, and sexes were included. A total of 53, 581 patients were identified with histologically confirmed papillary thyroid cancers.

Researchers found that the overall 5-year survival remained above 90% for all age groups under 65 years. It was not until age 65 years and older that patients had a progressively less favorable prognosis with each advancing age group.


Story Source:

The above story is based on materials provided by American Thyroid Association. Note: Materials may be edited for content and length.


Cite This Page:

American Thyroid Association. "Older age marker may be more appropriate for papillary thyroid cancer prognosis." ScienceDaily. ScienceDaily, 21 September 2012. <www.sciencedaily.com/releases/2012/09/120921123957.htm>.
American Thyroid Association. (2012, September 21). Older age marker may be more appropriate for papillary thyroid cancer prognosis. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2012/09/120921123957.htm
American Thyroid Association. "Older age marker may be more appropriate for papillary thyroid cancer prognosis." ScienceDaily. www.sciencedaily.com/releases/2012/09/120921123957.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) — Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) — According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins